Asmanex hfa and Entresto drug interactions - a phase IV clinical study of FDA data

Summary:

The phase IV clinical study analyzes what interactions people have when they take Asmanex hfa and Entresto. It is created by eHealthMe based on reports of 1 person who takes the same drugs from the FDA, and is updated regularly.

What is Asmanex hfa?

Asmanex hfa has active ingredients of mometasone furoate. eHealthMe is studying from 1,067 Asmanex hfa users. Check the latest studies of Asmanex hfa.

What is Entresto?

Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 126,623 Entresto users. Check the latest studies of Entresto.



On Apr, 18, 2026

1 person who takes Asmanex hfa and Entresto together, and has interactions is studied.

Asmanex hfa and Entresto drug interactions.

What are the common drug interactions of Asmanex Hfa and Entresto, by gender? *:

female:

  1. Abdominal pain upper
  2. Nausea (feeling of having an urge to vomit)
  3. Eosinophil count increased
  4. Hair colour changes
  5. Hepatic pain (pain in liver)
  6. Renal pain (kidney pain)

male:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Asmanex hfa and Entresto?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Asmanex hfa and Entresto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Asmanex hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Entresto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Asmanex hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Entresto and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate and sacubitril; valsartan (the active ingredients of Asmanex hfa and Entresto, respectively), and Asmanex hfa and Entresto (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: